Expansion of cardiac progenitors from reprogrammed fibroblasts as potential novel cardiovascular therapy
Witman N, Sahara M. Expansion of cardiac progenitors from reprogrammed fibroblasts as potential novel cardiovascular therapy. Stem Cell Investigation 2016, 3: 34-34. PMID: 27580668, PMCID: PMC4981704, DOI: 10.21037/sci.2016.07.06.Commentaries, Editorials and LettersHeart failureMyocardial infarctionEnd-stage heart failureSuccessful therapeutic optionStage heart failureHuman heartGraft dysfunctionHeart transplantIschemic injuryTherapeutic optionsHeart functionCardiovascular therapySevere injuriesImmune rejectionCardiac therapyAvailable donorsInjuryAdult cardiomyocytesMuscular organNovel cardiovascular therapiesRecipient listTherapyHeartIrreversible damageCell types
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply